Lv0
0 积分 2025-08-31 加入
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
16天前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
16天前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
17天前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
18天前
已完结
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer
19天前
已完结
Effect of Medial Patellofemoral Complex Reconstruction Technique on Patellofemoral Contact Pressure, Contact Area, and Kinematics
5个月前
已完结
SMARTphone Based Cardiovascular Risk Reduction in BREAST Cancer Patients (SMART-BREAST): A Randomised Controlled Trial Protocol
8个月前
已关闭
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
8个月前
已完结
Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
8个月前
已完结
Breast cancer
8个月前
已完结
皖公网安备34019202002308
